How Health Departments Are Advancing Viral Hepatitis Prevention and Care

By Chris Taylor, Director, Viral Hepatitis, NASTAD

NASTAD World Hepatitis Day 2014 White House Recognition

NASTAD Staff: Left to Right: Murray Penner, Deputy Director; Julie Scofield, Executive Director; Chris Taylor, Director, Viral Hepatitis

Last month, Julie Scofield, Executive Director of the National Alliance of State and Territorial AIDS Directors (NASTAD), was recognized by the White House Office of Drug Control Policy (ONDCP) and Office of National AIDS Policy (ONAP) for her leadership in the prevention and treatment of viral hepatitis. The event was held at the White House in observance World Hepatitis Day. NASTAD congratulates Julie Scofield and other colleagues recognized for their leadership to address the domestic and global viral hepatitis epidemics.

Continue reading

Is $1 Enough for Viral Hepatitis Prevention?

By Emily McCloskey, Manager, Policy and Legislative Affairs

Is 1$ Enough for Viral Hepatitis Prevention?Today, NASTAD released an infographic analyzing viral hepatitis funding. State health departments receive less than $1 dollar in federal funding for every person living with viral hepatitis for the Viral Hepatitis Prevention Coordinator (VHPC) program. The VHPC program is the only national program dedicated to the viral hepatitis epidemics and provides the only public health infrastructure for the prevention of viral hepatitis and linking individuals to care and treatment. In order to meet the goals established by the Viral Hepatitis Action Plan, the VHPC program must continue to be funded in all existing jurisdictions and increased resources are necessary to coordinate prevention efforts at the state and local levels. Continue reading

An Emerging Epidemic: The Public Health Response to Hepatitis C Infection among Young People who Inject Drugs

By Oscar Mairena, Manager, Viral Hepatitis/Policy and Legislative Affairs

Panelists at the NASTAD and Harm Reduction Coalition Congressional Briefing.

Panelists at the NASTAD and Harm Reduction Coalition Congressional Briefing.

Last year, the Viral Hepatitis Prevention Coordinator (VHPC) in Massachusetts, Dan Church, wrote a post about the increasing rate of acute hepatitis C (HCV) infection among young persons who inject drugs in Massachusetts and the health department’s efforts to prevent new infections, identify existing cases, educate individuals vulnerable to acquisition, and enhance surveillance and data collection to better address the epidemic. Since then, more health departments have reported this trend, especially among young persons who begin using prescription opioids and transition to injecting heroin. Earlier this week, NASTAD partnered with the Harm Reduction Coalition to host a Congressional Briefing, An Emerging Epidemic: The Public Health Response to Hepatitis C Infection among Young People who Use Drugs, to bring this issue to light, educate Congressional staff and reinforce the role of public health in addressing emerging health concerns. Continue reading

How Health Departments Are Addressing the Viral Hepatitis Epidemic in the U.S.

By Maria Courogen, Director of the Office of Infectious Disease, Washington State Department of Health

Maria Courogen

Maria Courogen, Washington State AIDS Director, speaking at the launch of the updated Viral Hepatitis Action Plan.

In my role in Washington State, I oversee the state health department’s work in the areas of HIV, sexually transmitted diseases (STDs), tuberculosis and viral hepatitis. In my role as a member of NASTAD’s Executive Committee and Chair-Elect, I work with state health department colleagues across the country, many of whom have a similar portfolio of work, to provide leadership in the country’s response to HIV and hepatitis. As such, On April 3, I participated in an event hosted by the U.S. Department of Health and Human Services (HHS) for the release of the next iteration of the Viral Hepatitis Action Plan.

Continue reading

Viral Hepatitis Prevention Coordinators Convene in DC

By Ronald Valdiserri, M.D., M.P.H., Deputy Assistant Secretary for Health, Infectious Diseases, and Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services

Cross-posted from AIDS.gov

Drs. Ron Valdiserri, Ellie McCance-Katz, and John Ward dicussing federal viral hepatitis initiatives with Viral Hepatitis Prevention Coordinators from across the country.

Drs. Ron Valdiserri, Ellie McCance-Katz, and John Ward dicussing federal viral hepatitis initiatives with Viral Hepatitis Prevention Coordinators from across the country.

Last week I had the opportunity to discuss the federal response to viral hepatitis with some of our key allies in the states: the CDC-funded Adult Viral Hepatitis Prevention Coordinators who had assembled in Washington, DC for the third National Hepatitis Technical Assistance meeting organized and hosted by the National Alliance of State and Territorial AIDS Directors (NASTAD). Continue reading